Lecture 6: how do drugs work Flashcards
Four primary drug tagets?
- ion channels
- enzymes
- carrier molecules
- receptors
the only exception being DNA for which some anti-tumour drugs and antimicrobial drugs bind to
4 steps of neurotransmission
- synthesis
- release
- receptors
- inactivation
key sites of action of drugs in neurotransmitter:
synthesis
release
reception
- choline trnsporter (for ACh synthesis)
Choline acetyl transferase (ChAT) -for choline synthesis
- Vesicular ACh transporter acks ACh into vesicles
Ca 2+ causes vessicle binding to membrane
- Ligand gated ion channels, G-protein couples receptors, tyrosine/cytokine kinase receptors, steroid/nuclear hormone receptors
4 types of channels
Ligand gated ion channels features?
- fast signal transmission
- multi-subunit complexes
- responds to specific ligands, select ions to let through
- conduct these ions through otherwise impermeable membranes
nicotinic acetylcholine receptors
the receptor pore?
- 5 subunits arranged around central channel
- each subunit has 4 transmembrane domains (20 total)
- each binding site sits between alpha subunit and adjacent subunit
- both binding sites needed to be occupied for channel opening
- onened by ACh binding
- aa in TM2 determies conductivity (usually Na+ and K+)
Ionotropic receptors as drug targets?
GABAA -Benzodiazapines and barbiturates (sedation and anxiolytic effects). Muscimol (hallucinogenic mushrooms)
Glutamate - ketamine (anaesthetic) have adverse effects
Nicotinic - nicotine, pancuronium (antagonsist) used as a muscle relaxants during anaesthetic
GPCRs?
- 7 transmembrane domains
- intracellular C terminal interacts with G protein
- Gαs = activates adenyl cyclase, ↑cAMP
- Gαi = inhibits adenyl cyclase, ↓cAMP
- Gαq = activates PLC (PIP2 —> DAG + IP3)
- Use Muscarinic receptors M1,2,3,4,5
GPCR pre-synaptic receptors?
- usually Gi linked
- activation leads to inhibition of voltage sensitive Ca2+ channels
- results in decreased neurotransmitter release
- FEEDBACK LOOP
- drugs can be targeted to block these decreasing release 10 fold
tyrosine kinase receptors
- receptor functions as an enzyme that transfers phosphate groups from ATP to tyrosine residues on intracellular target proteins (autophosphorylation)
- mediate action of growth factors, cytokines and certain hormones (eg insulin)
vascular endothelial growth factor receptors
- essential for angiogenesis during development, pregnancy, woud healing
- also in pathophysioloical conditions: cancer, rheumatoid arthritis, CVD
VEGFR2?
- ligand stimulated receptor dimerisation
- autophosphorylation of tyrosine residues in cytoplasmic domain
- associated with SH2 domain proteins
- work via big cascades (proliferation pathways)
proliferation pathways?
- receptor activation leads to PLCy activation by phosphorylation
- this hydrolyses PIP2 to DAG and IP3
- DAG activates PKC
- PKC activation leads to activation of ERK via Raf and MEK
- ERK activation leads to increased gene transcription
how do drugs bind to receptors? weak to strong
- Ven der waals forces
- hydrogen bonding
- ionic
- covalent - irreversible
Kd?
affinity constant = concentration when 50% is bound